Elixir Medical is proud to have been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2025. This year’s list shines a spotlight on businesses that are shaping ...

In patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) with stable coronary ...

To date, PCI has not improved mortality in CAD patients. The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial compared medical management to PCI in ...

Do the survival and MI-prevention benefits extend to stable CAD patients? In the COURAGE trial, 2287 patients (mean age, 62; 85% men; 33.5% with diabetes) were randomized to PCI plus optimal ...

Facilitated percutaneous coronary intervention (PCI) refers to using fibrinolytic therapy to stabilize the patient while transport is being arranged to a primary PCI facility. This strategy ...

Coronary artery disease (CAD) is a type of heart disease that occurs when your coronary arteries don’t supply enough blood to your heart. CAD often develops because of a waxy substance buildup called ...

Patients with low-risk stable CAD were randomized to PCI plus medical therapy (n = 192) versus medical therapy alone (n = 192). At baseline, for PCI vs. medical therapy, the use of antiplatelet ...

CAD is the most common type of heart disease ... Percutaneous coronary intervention (PCI) is a minimally invasive procedure to open blocked arteries using a stent. In this procedure, a ...

Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow ...

Medical management, percutaneous coronary intervention (PCI) and CABG surgery are all viable therapeutic strategies for coronary disease. The choice between these methods is made largely on the ...